5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme

Oncotarget

Volumn 6, Issue 27, 2015, Pages 24333-24347

  Ciccarone, Fabio ^a   Valentini, Elisabetta ^a   Zampieri, Michele ^a   Caiafa, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

5hmC; PARylation; TET1

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OXYGENASE; TET1 HYDROXYLASE; UNCLASSIFIED DRUG; 5-HYDROXYMETHYLCYTOSINE; CYTOSINE; GLUTATHIONE TRANSFERASE; MIXED FUNCTION OXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; PARP1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TET1 PROTEIN, HUMAN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STABILITY; GENE EXPRESSION; IN VITRO STUDY; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; DNA DAMAGE; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; HEK293 CELL LINE; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; PROTEIN PROCESSING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CYTOSINE; DNA DAMAGE; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84943395409     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4476     Document Type: Article

References (71)

1. Hottiger MO, Hassa PO, Luscher B, Schuler H and KochNolte F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends in biochemical sciences 2010;35(4):208-219.
2. Hassa PO and Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of polyADP-ribose polymerases. Front Biosci. 2008;13:3046-3082.
3. Schreiber V, Dantzer F, Ame JC and de Murcia G. Poly(ADP-ribose):novel functions for an old molecule. Nature reviews. 2006;7:517-528.
4. Zaja R, Mikoc A, Barkauskaite E and Ahel I. Molecular Insights into Poly(ADP-ribose) Recognition and Processing. Biomolecules 2012;3:1-17.
5. Beck C, Robert I, Reina-San-Martin B, Schreiber V and Dantzer F. Poly(ADP-ribose) polymerases in doublestrand break repair:focus on PARP1,PARP2 and PARP3. Experimental cell research 2014;329:18-25.
6. Burkle A and Virag L. Poly(ADP-ribose):PARadigms and PARadoxes. Molecular aspects of medicine 2013;34:1046-1065.
7. Bacalini MG, Di Lonardo D, Catizone A, Ciccarone F, Bruno T, Zampieri M, Guastafierro T, Calabrese R, Fanciulli M, Passananti C, Caiafa P, Reale A. Poly(ADPribosyl)ation affects stabilization of Che-1 protein in response to DNA damage. DNA Repair (Amst) 2011; 10:380-9.
8. El-Khamisy SF, Masutani M, Suzuki H and Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic acids research. 2003;31:5526-5533.
9. Fischer JM, Popp O, Gebhard D, Veith S, Fischbach A, Beneke S, Leitenstorfer A, Bergemann J, Scheffner M, Ferrando-May E, Mangerich A and Burkle A. Poly(ADPribose)-mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function. The FEBS journal 2014 281:3625-3641.
10. Malanga M, Pleschke JM, Kleczkowska HE and Althaus FR. Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions. The Journal of biological chemistry. 1998;273:11839-11843.
11. Guastafierro T, Cecchinelli B, Zampieri M, Reale A, Riggio G, Sthandier O, Zupi G, Calabrese L and Caiafa P. CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. The Journal of biological chemistry. 2008;283:21873-21880.
12. Sajish M and Schimmel P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 2015;519:370-3.
13. Krietsch J, Rouleau M, Pic E, Ethier C, Dawson TM, Dawson VL, Masson JY, Poirier GG and Gagne JP. Reprogramming cellular events by poly(ADP-ribose) binding proteins. Molecular aspects of medicine 2013; 34:10661087.
14. Guastafierro T, Catizone A, Calabrese R, Zampieri M, Martella O, Bacalini MG, Reale A, Di Girolamo M, Miccheli M, Farrar D, Klenova E, Ciccarone F and Caiafa P. ADP-ribose polymer depletion leads to nuclear Ctcf relocalization and chromatin rearrangement. The Biochemical journal 2013;449:623-630.
15. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M and Fukasawa K. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl) ation. Nature cell biology. 2007;9:1175-1183.
16. Krishnakumar R and Kraus WL. The PARP side of the nucleus:molecular actions, physiological outcomes, and clinical targets. Molecular cell 2010;39:8-24.
17. Krishnakumar R and Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5Bdependent pathway. Molecular cell 2010;39:736-749.
18. Pavri R, Lewis B, Kim TK, Dilworth FJ, ErdjumentBromage H, Tempst P, de Murcia G, Evans R, Chambon P and Reinberg D. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Molecular cell. 2005;18:83-96.
19. Reale A, Matteis GD, Galleazzi G, Zampieri M and Caiafa P. Modulation of DNMT1 activity by ADP-ribose polymers. Oncogene. 2005;24:13-19.
20. Martinez-Zamudio R and Ha HC. Histone ADP-ribosylation facilitates gene transcription by directly remodeling nucleosomes. Molecular and cellular biology 2012; 32:24902502.
21. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser D, Huang D, Caflisch A and Hottiger MO. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic acids research 2010;38:6350-6362.
22. Farrar D, Rai S, Chernukhin I, Jagodic M, Ito Y, Yammine S, Ohlsson R, Murrell A and Klenova E. Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Molecular and cellular biology 2010;30:1199-1216.
23. Gao F, Kwon SW, Zhao Y and Jin Y. PARP1 poly(ADPribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. The Journal of biological chemistry. 2009;284:22263-22273.
24. Quenet D, Gasser V, Fouillen L, Cammas F, SanglierCianferani S, Losson R and Dantzer F. The histone subcode: poly(ADP-ribose) polymerase-1 (Parp-1) and Parp-2 control cell differentiation by regulating the transcriptional intermediary factor TIF1beta and the heterochromatin protein HP1alpha. Faseb J. 2008;22:3853-3865.
25. Sala A, La Rocca G, Burgio G, Kotova E, Di Gesu D, Collesano M, Ingrassia AM, Tulin AV and Corona DF. The nucleosome-remodeling ATPase ISWI is regulated by polyADP-ribosylation. PLoS biology. 2008;6:e252.
26. Lodhi N, Kossenkov AV and Tulin AV. Bookmarking promoters in mitotic chromatin:poly(ADP-ribose) polymerase-1 as an epigenetic mark. Nucleic acids research 2014;42:7028-7038.
27. Le May N, Iltis I, Ame JC, Zhovmer A, Biard D, Egly JM, Schreiber V and Coin F. Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression. Molecular cell 2012;48:785-798.
28. De Vos M, El Ramy R, Quenet D, Wolf P, Spada F, Magroun N, Babbio F, Schreiber V, Leonhardt H, Bonapace IM and Dantzer F. Poly(ADP-ribose) polymerase 1 (PARP1) associates with E3 ubiquitin-protein ligase UHRF1 and modulates UHRF1 biological functions. The Journal of biological chemistry 2014;289:16223-16238.
29. Zampieri M, Passananti C, Calabrese R, Perilli M, Corbi N, De Cave F, Guastafierro T, Bacalini MG, Reale A, Amicosante G, Calabrese L, Zlatanova J and Caiafa P. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PloS one 2009; 4:e4717.
30. Ciccarone F, Klinger FG, Catizone A, Calabrese R, Zampieri M, Bacalini MG, De Felici M and Caiafa P. Poly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damageindependent roles. PloS one 2012;7:e46927.
31. Ciccarone F, Valentini E, Bacalini MG, Zampieri M, Calabrese R, Guastafierro T, Mariano G, Reale A, Franceschi C and Caiafa P. Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription. Oncotarget 2014;5:10356-10367.
32. Shen L and Zhang Y. 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Current opinion in cell biology 2013;25:289-296.
33. Piccolo FM and Fisher AG. Getting rid of DNA methylation. Trends in cell biology 2014;24:136-143.
34. Sun W, Guan M and Li X. 5-hydroxymethylcytosinemediated DNA demethylation in stem cells and development. Stem cells and development 2014;23:923-930.
35. Hashimoto H, Liu Y, Upadhyay AK, Chang Y, Howerton SB, Vertino PM, Zhang X and Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic acids research 2012;40:4841-4849.
36. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C and Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011; 333:1300-1303.
37. Shen L, Wu H, Diep D, Yamaguchi S, D'Alessio AC, Fung HL, Zhang K and Zhang Y. Genome-wide analysis reveals TET-and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013;153:692-706.
38. Bachman M, Uribe-Lewis S, Yang X, Williams M, Murrell A and Balasubramanian S. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nature chemistry 2014;6:1049-1055.
39. Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, Bruckl T, Biel M and Carell T. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PloS one 2010; 5:e15367.
40. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO, Feng S, Stroud H, Jacobsen SE and Pradhan S. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. The Journal of biological chemistry 2011;286:24685-24693.
41. Hon GC, Song CX, Du T, Jin F, Selvaraj S, Lee AY, Yen CA, Ye Z, Mao SQ, Wang BA, Kuan S, Edsall LE, Zhao BS, Xu GL, He C and Ren B. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Molecular cell 2014; 56:286-297.
42. Szulwach KE, Li X, Li Y, Song CX, Han JW, Kim S, Namburi S, Hermetz K, Kim JJ, Rudd MK, Yoon YS, Ren B, He C and Jin P. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS genetics 2011;7:e1002154.
43. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J and Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011;473:343-348.
44. Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, Kim A, Li X, Dai Q, Shen Y, Park B, Min JH, Jin P, Ren B and He C. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012;149:1368-1380.
45. Iurlaro M, Ficz G, Oxley D, Raiber EA, Bachman M, Booth MJ, Andrews S, Balasubramanian S and Reik W. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome biology 2013;14:R119.
46. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, Bauer C, Munzel M, Wagner M, Muller M, Khan F, Eberl HC, Mensinga A, Brinkman AB, Lephikov K, Muller U, Walter J, et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 2013; 152:1146-1159.
47. Kellinger MW, Song CX, Chong J, Lu XY, He C and Wang D. 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nature structural & molecular biology 2012; 19:831-833.
48. Neri F, Incarnato D, Krepelova A, Rapelli S, Anselmi F, Parlato C, Medana C, Dal Bello F and Oliviero S. Single Base Resolution Analysis of 5-Formyl and 5-Carboxyl Cytosine Reveals Promoter DNA Methylation Dynamics. Cell reports 2015.
49. Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR, Murat P, Oxley D, Booth MJ, Reik W and Balasubramanian S. Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome biology 2012;13:R69.
50. Roper SJ, Chrysanthou S, Senner CE, Sienerth A, Gnan S, Murray A, Masutani M, Latos P and Hemberger M. ADPribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells. Nucleic acids research 2014;42:8914-8927.
51. Fujiki K, Shinoda A, Kano F, Sato R, Shirahige K and Murata M. PPARgamma-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine. Nature communications 2013; 4:2262.
52. Joung JK and Sander JD. TALENs:a widely applicable technology for targeted genome editing. Nature reviews 2013;14:49-55.
53. Maeder ML, Angstman JF, Richardson ME, Linder SJ, Cascio VM, Tsai SQ, Ho QH, Sander JD, Reyon D, Bernstein BE, Costello JF, Wilkinson MF and Joung JK.Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nature biotechnology 2013;31:1137-1142.
54. Delatte B, Deplus R and Fuks F. Playing TETris with DNA modifications. The EMBO journal 2014;33:1198-1211.
55. Dehennaut V, Leprince D and Lefebvre T. O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins. Frontiers in endocrinology 2014;5:155.
56. Shi FT, Kim H, Lu W, He Q, Liu D, Goodell MA, Wan M and Songyang Z. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. The Journal of biological chemistry 2013; 288:2077620784.
57. Zhang Q, Liu X, Gao W, Li P, Hou J, Li J and Wong J. Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked beta-Nacetylglucosamine transferase (OGT). The Journal of biological chemistry 2014;289:5986-5996.
58. Bauer C, Gobel K, Nagaraj N, Colantuoni C, Wang M, Muller U, Kremmer E, Rottach A and LeonhardtOGlcNAcylation by the O-Linked N-Acetylglucosamine Transferase (OGT). The Journal of biological chemistry 2015;290:4801-4812.
59. Deplus R, Delatte B, Schwinn MK, Defrance M, Mendez J, Murphy N, Dawson MA, Volkmar M, Putmans P, Calonne E, Shih AH, Levine RL, Bernard O, Mercher T, Solary E, Urh M, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.The EMBO journal 2013;32:645-655.
60. Dhliwayo N, Sarras MP, Jr., Luczkowski E, Mason SM and Intine RV. Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation. Diabetes 2014;63:3069-3076.
61. Rosenthal F, Messner S, Roschitzki B, Gehrig P, Nanni P and Hottiger MO. Identification of distinct amino acids as ADP-ribose acceptor sites by mass spectrometry. Methods in molecular biology 2011;780:57-66.
62. Zampieri M, Guastafierro T, Calabrese R, Ciccarone F, Bacalini MG, Reale A, Perilli M, Passananti C and Caiafa P. ADP-ribose polymers localized on Ctcf-Parp1-Dnmt complex prevent methylation of Ctcf target sites. TheBiochemical journal 2012;441:645-652.
63. Jin C, Lu Y, Jelinek J, Liang S, Estecio MR, Barton MC and Issa JP. TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic acids research 2014;42:6956-6971.
64. Williams K, Christensen J and Helin K. DNA methylation: TET proteins-guardians of CpG islands? EMBO reports 2011;13:28-35.
65. Wu H, D'Alessio AC, Ito S, Xia K, Wang Z, Cui K, Zhao K, Sun YE and Zhang Y. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011;473:389-393.
66. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP and Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010;468:839-843.
67. Kroeze LI, van der Reijden BA and Jansen JH. 5-Hydroxymethylcytosine:An epigenetic mark frequently deregulated in cancer. Biochimica et biophysica acta 2015; 1855:144-154.
68. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, Guan KL and Xiong Y. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013;32:663-669.
69. Al-Mahdawi S, Virmouni SA and Pook MA. The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases. Frontiers in neuroscience 2014;8:397.
70. Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, Ricigliano VA, Zampieri M, Annibali V, Mechelli R, Franceschi C, Salvetti M and Caiafa P. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells. Biochimica et biophysica acta 2014;1842:1130-1136.
71. Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA and Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiology of aging 2014;35:1334-1344.